Olema Pharmaceuticals, Inc. (OLMA)
28.81
+0.73
(+2.60%)
USD |
NASDAQ |
Jan 12, 16:00
28.81
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Research and Development Expense (Quarterly): 39.95M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Cidara Therapeutics, Inc. | 35.53M |
| Cogent Biosciences, Inc. | 67.84M |
| Replimune Group, Inc. | 57.65M |
| Genprex, Inc. | 2.193M |